Mar 15, 2026 | News, Videos
The research developed by Hemera was featured in the TG4 Medicina, an in-depth health and innovation program within the national news broadcast of Rete 4 dedicated to medical and scientific topics. The interview featured Ilaria Decimo, Co-Founder and Director of...
Mar 10, 2026 | News, Press Releases
The research of Hemera was featured on the Smart City podcast on Radio 24, dedicated to scientific and technological innovation, in an interview with Ilaria Decimo, co-founder and Director of Research & Development at Hemera. The episode addressed one of the most...
Feb 26, 2026 | News, Press Review
From TG3 Leonardo to national media: press recognition supports Hemera’s path toward the clinical phase Following the recent publication in the prestigious international journal Immunity by Cell Press of data related to the REMaST® cell therapy, Hemera is pleased to...
Feb 20, 2026 | Events, News
At the 2026 International Cancer Neuroscience Symposium in Houston (USA) the prestigious scientific forum organized by MD Anderson Cancer Center and Advanced Portfolio, Professor Francesco Bifari, co-founder and Director of Therapy Development at Hemera, was invited...
Feb 11, 2026 | News, Press Releases
Immunity by Cell Press dedicates the cover of Volume 59, Issue 2,10 February 2026 to our study reporting the preclinical data underpinning the REMaST® therapeutic platform. Cristiana Vignoli, CEO of Hemera, stated:“The cover of Immunity confirms the value of Italian...
Jan 26, 2026 | News, Press Releases
A peer-reviewed study demonstrates the therapeutic potential of REMaST® in spinal cord repair and neuronal regeneration Hemera is pleased to announce the online preprint publication of the manuscript “Tumor-associated macrophages enhance peripheral nerve tumor...
